Trial Profile
High Loading ROsuvastatin Pretreatment in Patients Undergoing Elective PCI to Reduce the Incidence of MyocArdial Periprocedural Necrosis : Comparison With Atorvastatin High Dose Reloading.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Coronary artery disease; Muscle necrosis; Myocardial infarction
- Focus Adverse reactions; Biomarker
- 11 Dec 2015 New trial record